Product Details
No Coding Diabetes Blood Sugar Test
Machine In Accuracy Result Safe
Accu 200 test results MOQ 3000
SAFE-ACCU
BLOOD GLUCOSE MONITORING SYSTE
SPECIFICATION
Blood sample | Fresh capillary whole blood |
Test range | 20-600mg/dL(1.1-33.3mmol/L) |
Test time | 10s |
Blood volume | 0.6ul |
HCT range | 30-60% |
Expiry date | 24 months |
Memory | 200 test results |
Lifetimeof battery | ≥ 1000 times |
Features
1.Memory with capacity for 200 results
2.Automatic strips ejections
3.0.6 ul blood sample
4.No coding
5.Virtually pain free glucose testing
6.Automatically applying blood sample
Application
- The Safe-Accu Blood Glucose Monitoring system is intended for use
outside the body(in vitro diagnostic use) and should not be used
for the diagnosis of or screening of diabetes.
- The Safe-Accu Blood Glucose Test Strip is intended to be used with
the Safe-Accu Blood Glucose Meter to quantitatively measure
glucose(sugar) in capillary whole blood samples drawn from the
fingertips or venous whole blood samples.
- The Safe-Accu Blood Glucose Test Strip is intended for use by
people with diabetes mellitus in the home and by healthcare
professionals in clinical setting as an aid in monitoring the
effectiveness of diabetes control.
WARNINGS
1.Do not use for neonates (newborns or infants).
2.Do not use to screen or diagnose diabetes mellitus.
3.Do not use for critically patients.
4.All parts of the Safe-Accu kit should be treated as biohazard and
can transmit infectious diseases, even after you clean and
disinfect.
5.Keep test strip vial away from children. A child could choke on
the cap or be harmed if the drying agent in vial is swallowed,
inhaled, or contacts skin.
The biggest Blood Glucose Monitoring System production base in
Asia.
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology.
Company Profile
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology. Since its inception in 2002, has
been adhering to the business purpose “Honor Commitment Dedicate to
Healthcare", focus on promoting the development of diabetes health.
Sinocare is a high-tech enterprise dedicated to the development,
production and sales of the rapid detection of chronic diseases in
the use of bio sensing technology. Since its inception in 2002, has
been adhering to the business purpose “Honor Commitment Dedicate to
Healthcare", focus on promoting the development of diabetes health.
Sinocare as a national high-tech industrialization demonstration
project, has won National Innovation Fund support, and took the
lead through the ISO 13485 Quality Management System certification
and the CE certification of EU. The SANNUO series blood glucose
meter and a test strips, with the characteristics of the "accuracy,
simple and economic", recognized by the vast number of consumers,
the "Sinocare" trademark was identified as "China well known
trademark by State Administration of industry and Commerce of. The
products are not only popular in China, but also in the
international market. In March 19, 2012, the company listed on the
Shenzhen stock exchange gem, as the first Bio sensor stock in
China. In 2015, the blood glucose meter in the domestic retail
market share reached 51%, becoming the industry leader in blood
glucose monitoring products, the same year was elected to the
Forbes Asian small and medium companies top 200 list. In 2014
September,Sinocare acquired Beijing Jianheng Diabetes Hospital,to
step into health service area. In January of 2016, Sinocare
acquired Nipro diagnostic Inc. (now renamed as Trividia Health
Inc.), the world's sixth BGM enterprise, and reached the
international leading BGM corporation, In July of 2016, completed
acquisition of PTS Diagnostics, expand the POCT testing business,
to provide a more comprehensive solution for chronic disease
prevention.